Delveinsight

OCTOBER 4, 2021

The present Myocardial infarction treatment market comprises Antiplatelet agents, Anticoagulants, Vasodilators, Beta Blockers, Lipid-lowering drug/ Statins, ACE inhibitors, ARBs (Angiotensin-II receptor Blockers), and Calcium channel blockers.

Marketing 76

Marketing Clinical Trials Clinical Trials Drugs 76

pharmaphorum

AUGUST 18, 2020

Livongo provides tools that slot into the daily lives of patients with conditions like diabetes and hypertension, helping them manage their conditions, and has seen revenues and users of its services rise exponentially in recent months. Its second-quarter revenue leaped 125% to almost $92 million.

Doctors 70

Doctors Doctor Sales Marketing 70

XTalks

SEPTEMBER 29, 2022

In addition to funding important clinical research, the AHA provides some of the most important channels in which clinical trial results get published, disseminated and implemented.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Research 52

The Pharma Data

JUNE 26, 2021

3%) are constipation, anxiety, diarrhoea, insomnia, hypertension and nausea. Roche has existing distribution channels established to ship Actemra/RoActemra to hospitals across the United States. There have been no new safety signals identified for Actemra/RoActemra in any of these studies.

Clinical Trials 40

Clinical Trials Clinical Trials In-Vitro Antibody 40

Pfizer

JANUARY 27, 2023

PAXLOVID is contraindicated with drugs that are highly dependent on CYP3A for clearance and for which elevated concentrations are associated with serious and/or life-threatening reactions: Alpha1-adrenoreceptor antagonist: alfuzosin Antianginal: ranolazine Antiarrhythmic: amiodarone, dronedarone, flecainide, propafenone, quinidine Anti-gout: colchicine (..)

Marketing 75

Marketing Production Drugs Licensing 75

The Pharma Data

NOVEMBER 24, 2021

Manufacturing and Supply Chain Information The Janssen COVID-19 single- cure vaccine is compatible with standard vaccine storehouse and distribution channels with ease of delivery to remote areas. Source link: [link].

Vaccination 52

Vaccination Vaccine Manufacturing Clinical Trials 52

Pfizer

DECEMBER 20, 2022

PDE5 inhibitor: sildenafil (Revatio®) when used for pulmonary arterial hypertension. 1 IQVIA National Prescription Audit data through December 4, 2022, containing retail pharmacy, mail order and long-term care channels; U.S. Department of Health and Human Services data through December 11, 2022, for non-retail channels.

Drugs 69

Drugs Licensing Licensing Containment 69

The Pharma Data

NOVEMBER 23, 2021

Taking aspirin was independently associated with a 26% raised risk of a new heart failure diagnosis.

Cardiology 52

Cardiology Development Drugs Research 52

The Pharma Data

MARCH 8, 2022

“From the outset of this pandemic we aimed to develop a simple-to-use and accessible vaccine that could be transported around the world through standard vaccine distribution channels,” said Martin Fitchet, M.D., Head of Global Public Health, Johnson & Johnson, Cilag GmbH International. “We

Manufacturing 40

Manufacturing Vaccination Vaccine Contract Manufacturing 40

Pfizer

DECEMBER 13, 2022

PDE5 inhibitor: sildenafil (Revatio®) when used for pulmonary arterial hypertension. Migraine medications: eletriptan, ubrogepant. Mineralocorticoid receptor antagonists: finerenone. Opioid antagonists: naloxegol. Sedative/hypnotics: triazolam, oral midazolam. Serotonin receptor 1A agonist/serotonin receptor 2A antagonist: flibanserin.

Drugs 110

Drugs Licensing Licensing Production 110

pharmaphorum

JANUARY 14, 2021

The US, Japanese and Chinese promotional environments saw contact volumes recover to close to or greater than 2019 levels, with a channel mix that was more heavily remote.

Sales 66

Sales Marketing Production Medicine 66

The Pharma Data

SEPTEMBER 23, 2020

This makes the vaccine candidate compatible with standard vaccine distribution channels and would not require new infrastructure to get it to the people who need it. With Janssen’s AdVac ® technology, the vaccine, if successful, is estimated at launch to remain stable for two years at -20 °C and at least three months at 2-8° C.

Clinical Trials 52

Clinical Trials Clinical Trials Vaccination Vaccine 52

Pfizer

NOVEMBER 23, 2022

PDE5 inhibitor: sildenafil (Revatio®) when used for pulmonary arterial hypertension. Migraine medications: eletriptan, ubrogepant. Mineralocorticoid receptor antagonists: finerenone. Opioid antagonists: naloxegol. Sedative/hypnotics: triazolam, oral midazolam. Serotonin receptor 1A agonist/serotonin receptor 2A antagonist: flibanserin.

Licensing 40

Licensing Licensing Drugs Manufacturing 40

The Pharma Data

SEPTEMBER 23, 2020

This makes the vaccine candidate compatible with standard vaccine distribution channels and would not require new infrastructure to get it to the people who need it. With Janssen’s AdVac ® technology, the vaccine, if successful, is estimated at launch to remain stable for two years at -20 °C and at least three months at 2-8° C.

Clinical Trials 40

Clinical Trials Clinical Trials Vaccination Vaccine 40

XTalks

AUGUST 2, 2023

5) Adalat (nifedipine) Adalat, first approved by the FDA in 1981, is a medication classified as a calcium channel blocker. 2) Norvasc (amlodipine besylate) Norvasc is a calcium channel blocker that works to relax blood vessels, which helps to reduce blood pressure and makes it easier for the heart to pump blood.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

The Pharma Data

JULY 8, 2021

The Johnson & Johnson COVID-19 single-dose vaccine is compatible with standard vaccine storage and distribution channels with ease of delivery to remote areas. Storage and Distribution. The vaccine is estimated to remain stable for two years at -4°F (-20°C), and a maximum of 4.5 Source link: [link].

Vaccination 52

Vaccination Vaccine Immune Response Antibody 52

The Pharma Data

JANUARY 29, 2021

In addition, the Janssen vaccine candidate is compatible with standard vaccine distribution channels. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension. Follow us at @JanssenGlobal .

Vaccination 40

Vaccination Vaccine Trials Immune Response 40